Stevanato Group (NYSE:STVN) Shares Down 7.8% – Here’s Why

Stevanato Group S.p.A. (NYSE:STVN) fell 7.8% during trading on Tuesday . The company traded as low as €20.71 ($22.51) and last traded at €20.83 ($22.64). 76,087 shares traded hands during trading, a decline of 78% from the average session volume of 345,984 shares. The stock had previously closed at €22.60 ($24.57).

Analyst Upgrades and Downgrades

STVN has been the topic of several recent analyst reports. UBS Group reduced their price objective on shares of Stevanato Group from $24.00 to $23.50 and set a “neutral” rating on the stock in a research note on Friday. William Blair restated an “outperform” rating on shares of Stevanato Group in a report on Friday. Morgan Stanley reaffirmed an “equal weight” rating and issued a $23.00 price objective (down previously from $24.00) on shares of Stevanato Group in a research report on Tuesday, December 3rd. Wolfe Research initiated coverage on Stevanato Group in a research report on Friday, December 13th. They set an “outperform” rating and a $28.00 target price on the stock. Finally, Bank of America upped their price objective on shares of Stevanato Group from $24.00 to $26.00 and gave the company a “buy” rating in a research note on Friday, December 13th. Two investment analysts have rated the stock with a hold rating and six have assigned a buy rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average price target of €27.75 ($30.16).

Stevanato Group Trading Down 6.2 %

The company has a market capitalization of $6.42 billion, a PE ratio of 45.11, a P/E/G ratio of 7.18 and a beta of 0.60. The company has a debt-to-equity ratio of 0.22, a quick ratio of 1.21 and a current ratio of 1.81. The business has a fifty day moving average price of €21.40 and a 200 day moving average price of €20.57.

Stevanato Group (NYSE:STVN) last announced its quarterly earnings results on Thursday, March 6th. The company reported €0.20 ($0.22) earnings per share for the quarter, meeting analysts’ consensus estimates of €0.20 ($0.22). Stevanato Group had a net margin of 10.47% and a return on equity of 9.86%. The firm had revenue of €352.68 million for the quarter, compared to analysts’ expectations of €346.26 million. Analysts expect that Stevanato Group S.p.A. will post 0.5 EPS for the current fiscal year.

Institutional Trading of Stevanato Group

Several large investors have recently added to or reduced their stakes in STVN. Van Berkom & Associates Inc. purchased a new stake in shares of Stevanato Group in the fourth quarter worth about $39,000. Johnson Financial Group Inc. acquired a new position in Stevanato Group during the 4th quarter worth approximately $41,000. Wells Fargo & Company MN boosted its holdings in Stevanato Group by 680.3% in the 4th quarter. Wells Fargo & Company MN now owns 3,246 shares of the company’s stock worth $71,000 after acquiring an additional 2,830 shares during the period. PNC Financial Services Group Inc. grew its position in Stevanato Group by 1,457.6% in the fourth quarter. PNC Financial Services Group Inc. now owns 5,654 shares of the company’s stock valued at $123,000 after acquiring an additional 5,291 shares in the last quarter. Finally, Tower Research Capital LLC TRC raised its stake in shares of Stevanato Group by 202.8% during the fourth quarter. Tower Research Capital LLC TRC now owns 7,413 shares of the company’s stock valued at $162,000 after purchasing an additional 4,965 shares during the period.

About Stevanato Group

Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering.